Neochem Bio Solutions Limited
Neochem Bio Solutions Limited (NEOCHEM): company summary
The company's business is improving, with annual revenue rising 31.8% and annual net profit rising 71.9%.
Neochem Bio Solutions Limited (NEOCHEM) is a micro-cap Chemicals company valued at ₹191 crore operating in Specialty Chemicals on the NSE and BSE.
- Recent price move
- Neochem Bio Solutions Limited last traded at ₹110.9, modestly up 1.19% on the day.
- Recent developments
- On 2026-03-31, the company reported its latest financial results, showing revenue of ₹65 crore and net profit of ₹7 crore for the quarter. Promoter holding fell by 24.40 percentage points to 66.72%, while domestic institutional holding rose by 15.82 percentage points to 15.82%. Foreign institutional holding dropped by 1.81 percentage points to 0.18%.
- Financial performance
- The company's business is improving, with annual revenue rising 31.8% and annual net profit rising 71.9%. The latest quarter shows revenue up 38.3% and net profit up 16.7% compared to the same quarter a year earlier. The net profit margin widened 2.5 percentage points to 10.9%, while return on equity and return on capital employed remain at 15.3% and 21.4%, respectively.
- Valuation multiples
- The stock trades at 15.8 times earnings, 2.25 times book value.
- Things to watch
- The company's promoter holding decreased significantly in the quarter. The stock is 16.5% below its 52-week high. The company has not paid out any dividends despite reporting repeated profits.
- Where it stands
- Neochem Bio Solutions Ltd ended the quarter with revenue of ₹65 crore and net profit of ₹7 crore. The stock is 16.5% below its 52-week high, and promoter holding fell by 24.40 percentage points. The company's net profit margin widened to 10.9%.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (10.0) and momentum (7.5), but weakest on quality (5.5).
DocStoX score
Low confidenceAt a glance
Key highlights
- Profit compounding 129% a year
- Revenue compounding 32% a year
- Low leverage — D/E 0.23
- Small ₹191 cr company — thinner liquidity
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Specialty Chemicals
Explore Neochem Bio Solutions Limited’s valuation
Free deep-dive tools · no sign-up
Neochem Bio Solutions Limited peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Neochem Bio Solutions Limited with the ratios and calculators DocStoX uses in its analysis.

